CHARLOTTETOWN, Prince Edward Island and SANTA CLARA, California – July 22, 2024
BIOVECTRA Inc. and Agilent Technologies, Inc. (NYSE: A) today announced the signing of an agreement for Agilent to acquire BIOVECTRA, a Canadian-based Contract Development and Manufacturing Organization, from H.I.G. Capital for $925 million.
The acquisition provides the ability to expand the range of capabilities available to global pharmaceutical partners working on next-generation treatments and therapeutics that will improve patients’ lives.
“Today is a testament to the reputation BIOVECTRA has built as a trusted …
0
Log In or Sign Up to add a comment.- 1
arrow-eseek-eNo items to display